Chemoinformaics analysis of 5-[(1E)-dodec-1-en-1-yl]-2H-1,3-benzodioxole
Molecular Weight | 288.431 | nRot | 10 |
Heavy Atom Molecular Weight | 260.207 | nRig | 11 |
Exact Molecular Weight | 288.209 | nRing | 2 |
Solubility: LogS | -6.689 | nHRing | 1 |
Solubility: LogP | 6.733 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 52.0042 |
nHD | 0 | BPOL | 31.5618 |
QED | 0.494 |
Synth | 2.092 |
Natural Product Likeliness | 0.78 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.993 |
Pgp-sub | 0.043 |
HIA | 0.001 |
CACO-2 | -4.884 |
MDCK | 0.0000191 |
BBB | 0.268 |
PPB | 0.985502 |
VDSS | 2.766 |
FU | 0.0147447 |
CYP1A2-inh | 0.967 |
CYP1A2-sub | 0.183 |
CYP2c19-inh | 0.857 |
CYP2c19-sub | 0.095 |
CYP2c9-inh | 0.409 |
CYP2c9-sub | 0.955 |
CYP2d6-inh | 0.961 |
CYP2d6-sub | 0.894 |
CYP3a4-inh | 0.934 |
CYP3a4-sub | 0.123 |
CL | 10.751 |
T12 | 0.109 |
hERG | 0.328 |
Ames | 0.015 |
ROA | 0.013 |
SkinSen | 0.953 |
Carcinogencity | 0.612 |
EI | 0.974 |
Respiratory | 0.314 |
NR-Aromatase | 0.724 |
Antiviral | Yes |
Prediction | 0.60008 |